Key result
Application of cariporide during extracellular realkalinization significantly delayed intracellular pH recovery and reduced endothelial cell activation markers in HUVECs.
Why the study?
Does cariporide reduce endothelial cell activation during simulated reperfusion in human umbilical vein endothelial cells?
Does cariporide reduce endothelial cell activation during simulated reperfusion in human umbilical vein endothelial cells?
Inhibition of the Na+/H+ exchanger with cariporide delays intracellular pH recovery and decreases endothelial cell activation during simulated reperfusion.
Answers are grounded in this paper and cite their sources.
Does not support clinical use of cariporide; hypothesis-generating for NHE inhibition in endothelial protection during reperfusion.
Reperfusion after ischemic conditions induces massive endothelial cell (EC) activation, an initial step of reperfusion injury. Reperfusion is characterized by reoxygenation, realkalinization and a localized increase of inflammatory stimuli. In this study, we focused on the influence of extracellular realkalinization on human umbilical vein endothelial cell (HUVEC) activation. We examined intracellular pH (pH(in)) and intracellular free calcium concentration ([Ca(2+)](in)), a second messenger known to mediate von Willebrand factor (VWF) exocytosis in endothelium, upon realkalinization. Furthermore, we measured the agonist-stimulated exocytosis of VWF, Interleukin-8 and soluble P-selectin (sP-Selectin) as markers of EC activation. To verify a morphological correlate of EC activation, we finally observed platelet-endothelial adherence during realkalinization using shear flow. Realkalinization of HUVEC was simulated by switching from bicarbonate buffered Ringer solution of an acidotic pH(ex) of 6.4 to a physiologic pH(ex) of 7.4. Extracellular realkalinization was accompanied by pH(in) recovery from 6.5 to 7.2 within 10 min. Application of cariporide, an inhibitor of the Na(+)/H(+) exchanger subtype 1 (NHE), during extracellular realkalinization significantly delayed the early kinetics of intracellular realkalinization. Histamine stimulated [Ca(2+)](in) was significantly increased upon realkalinization compared to control cells. Also agonist-stimulated release of VWF, Interleukin-8 and sP-Selectin was massively enhanced during pH(in) recovery in comparison to control. Furthermore, we observed an increased platelet binding to endothelium. Interestingly, each of these realkalinization-induced effects were significantly reduced by early application of cariporide. Therefore, delay of acute NHE-dependent pH(in) recovery may represent a promising mechanism for inhibition of EC activation upon reperfusion.
No takes yet. Share an insight, caveat, or question.
Huck et al. (2006) studied Endothelial cell activation upon reperfusion. Cariporide vs. Control cells was evaluated on Intracellular pH recovery and endothelial cell activation markers (VWF, Interleukin-8, sP-Selectin). Application of cariporide during extracellular realkalinization significantly delayed intracellular pH recovery and reduced endothelial cell activation markers in HUVECs.
Synapse has enriched 10 related papers. Consider them for comparative context: